ACE and liver dysplastic nodule: A synthetic curcumin analogue C66, targeting MAPKs, could decrease HG-induced ACE/Ang II/TGF-β1 both in vitro and in vivo, and attenuated diabetic renal fibrosis and pathological injury in mice, further indicating that C66 is a potential candidate for the treatment of DN.